LMR Partners’s Trillium Therapeutics Inc. TRIL Stock Holding History

LMR Partners’s Portfolio TRIL Stock Details TRIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-302,522	Closed	-$5.31M	–	1401
2021 Q3	$5.31M	Buy	+302,522	New	+$3.53M	0.06%	242

Other funds holding TRIL

Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return

LMR Partners's TRIL Position: Q4 2021 in Review

LMR Partners sold out of Trillium Therapeutics Inc. (TRIL) in Q4 2021, closing a stake of 302,522 shares — an estimated $5.31M sold.

LMR Partners first reported a position in TRIL in Q3 2021 and held it in 1 quarter. The position peaked at $5.31M in Q3 2021. 2 funds tracked by Wall St. Rank hold TRIL as of Q4 2021.

LMR Partners reported no remaining Trillium Therapeutics Inc. position as of Q4 2021 after selling out during the quarter.
LMR Partners sold 302,522 Trillium Therapeutics Inc. shares in Q4 2021, an estimated $5.31M.
LMR Partners first reported a position in Trillium Therapeutics Inc. in Q3 2021 and held it in 1 quarter.
LMR Partners's Trillium Therapeutics Inc. position peaked at $5.31M in Q3 2021.
2 funds tracked by Wall St. Rank held Trillium Therapeutics Inc. as of Q4 2021.

Based on LMR Partners's 13F filing for Q4 2021, filed 14 Feb 2022.